Gilead Sciences (GILD)

Add to Watchlists
Create an Alert
72.86 +1.26  +1.76% NASDAQ Apr 22, 8:00PM BATS Real time Currency in USD

Gilead Sciences Revenue (Quarterly):

3.120B for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

Gilead Sciences Revenue (Quarterly) Chart

Export Data
Save Image

Gilead Sciences Historical Revenue (Quarterly) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 3.120B
Sept. 30, 2013 2.783B
June 30, 2013 2.767B
March 31, 2013 2.532B
Dec. 31, 2012 2.588B
Sept. 30, 2012 2.427B
June 30, 2012 2.405B
March 31, 2012 2.282B
Dec. 31, 2011 2.200B
Sept. 30, 2011 2.122B
June 30, 2011 2.137B
March 31, 2011 1.926B
Dec. 31, 2010 1.999B
Sept. 30, 2010 1.938B
June 30, 2010 1.927B
March 31, 2010 2.086B
Dec. 31, 2009 2.032B
Sept. 30, 2009 1.801B
June 30, 2009 1.647B
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
   
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Dec. 31, 2005 Upgrade
Sept. 30, 2005 Upgrade
June 30, 2005 Upgrade
March 31, 2005 Upgrade
Dec. 31, 2004 Upgrade
Sept. 30, 2004 Upgrade
June 30, 2004 Upgrade
March 31, 2004 Upgrade
Dec. 31, 2003 Upgrade
Sept. 30, 2003 Upgrade
June 30, 2003 Upgrade
March 31, 2003 Upgrade
Dec. 31, 2002 Upgrade
Sept. 30, 2002 Upgrade
June 30, 2002 Upgrade
March 31, 2002 Upgrade
Dec. 31, 2001 Upgrade
Sept. 30, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Revenues

Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.

While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More

Get data for
Advertisement

GILD Revenue (Quarterly) Benchmarks

Companies
Amgen 5.011B
Pfizer 13.56B
Celgene 1.756B

GILD Revenue (Quarterly) Range, Past 5 Years

Minimum 1.647B Jun 2009
Maximum 3.120B Dec 2013
Average 2.248B
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.